New Research Offers Hope in Extensive-Stage Small-Cell Lung Cancer Maintenance
Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis
Extensive-stage small-cell lung cancer (ES-